These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
434 related articles for article (PubMed ID: 19588447)
21. Long-acting beta2-agonists for chronic asthma in adults and children where background therapy contains varied or no inhaled corticosteroid. Walters EH; Gibson PG; Lasserson TJ; Walters JA Cochrane Database Syst Rev; 2007 Jan; 2007(1):CD001385. PubMed ID: 17253458 [TBL] [Abstract][Full Text] [Related]
22. Combination fluticasone and salmeterol versus fixed dose combination budesonide and formoterol for chronic asthma in adults and children. Lasserson TJ; Ferrara G; Casali L Cochrane Database Syst Rev; 2011 Dec; 2011(12):CD004106. PubMed ID: 22161385 [TBL] [Abstract][Full Text] [Related]
23. Long-acting muscarinic antagonists (LAMA) added to inhaled corticosteroids (ICS) versus the same dose of ICS alone for adults with asthma. Anderson DE; Kew KM; Boyter AC Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD011397. PubMed ID: 26301488 [TBL] [Abstract][Full Text] [Related]
24. Intermittent versus daily inhaled corticosteroids for persistent asthma in children and adults. Chauhan BF; Chartrand C; Ducharme FM Cochrane Database Syst Rev; 2012 Dec; 12():CD009611. PubMed ID: 23235678 [TBL] [Abstract][Full Text] [Related]
25. Intermittent versus daily inhaled corticosteroids for persistent asthma in children and adults. Chauhan BF; Chartrand C; Ducharme FM Cochrane Database Syst Rev; 2013 Feb; (2):CD009611. PubMed ID: 23450606 [TBL] [Abstract][Full Text] [Related]
26. Long-acting beta2-agonists as an inhaled corticosteroid-sparing agent for chronic asthma in adults and children. Gibson PG; Powell H; Ducharme F Cochrane Database Syst Rev; 2005 Oct; 2005(4):CD005076. PubMed ID: 16235393 [TBL] [Abstract][Full Text] [Related]
27. Inhaled corticosteroids or long-acting beta-agonists alone or in fixed-dose combinations in asthma treatment: a systematic review of fluticasone/budesonide and formoterol/salmeterol. Frois C; Wu EQ; Ray S; Colice GL Clin Ther; 2009 Dec; 31(12):2779-803. PubMed ID: 20110019 [TBL] [Abstract][Full Text] [Related]
28. Long-acting muscarinic antagonists (LAMA) added to combination long-acting beta2-agonists and inhaled corticosteroids (LABA/ICS) versus LABA/ICS for adults with asthma. Kew KM; Dahri K Cochrane Database Syst Rev; 2016 Jan; 2016(1):CD011721. PubMed ID: 26798035 [TBL] [Abstract][Full Text] [Related]
29. Addition to inhaled corticosteroids of long-acting beta2-agonists versus anti-leukotrienes for chronic asthma. Ducharme FM; Lasserson TJ; Cates CJ Cochrane Database Syst Rev; 2011 May; (5):CD003137. PubMed ID: 21563136 [TBL] [Abstract][Full Text] [Related]
30. Inhaled steroids with and without regular salmeterol for asthma: serious adverse events. Cates CJ; Schmidt S; Ferrer M; Sayer B; Waterson S Cochrane Database Syst Rev; 2018 Dec; 12(12):CD006922. PubMed ID: 30521673 [TBL] [Abstract][Full Text] [Related]
31. Safety of regular formoterol or salmeterol in adults with asthma: an overview of Cochrane reviews. Cates CJ; Wieland LS; Oleszczuk M; Kew KM Cochrane Database Syst Rev; 2014 Feb; 2014(2):CD010314. PubMed ID: 24504983 [TBL] [Abstract][Full Text] [Related]
32. Regular treatment with salmeterol and inhaled steroids for chronic asthma: serious adverse events. Cates CJ; Jaeschke R; Schmidt S; Ferrer M Cochrane Database Syst Rev; 2013 Mar; (3):CD006922. PubMed ID: 23543548 [TBL] [Abstract][Full Text] [Related]
33. Combined corticosteroid and long-acting beta(2)-agonist in one inhaler versus inhaled corticosteroids alone for chronic obstructive pulmonary disease. Nannini LJ; Poole P; Milan SJ; Kesterton A Cochrane Database Syst Rev; 2013 Aug; 2013(8):CD006826. PubMed ID: 23990350 [TBL] [Abstract][Full Text] [Related]
34. Inhaled steroids with and without regular formoterol for asthma: serious adverse events. Janjua S; Schmidt S; Ferrer M; Cates CJ Cochrane Database Syst Rev; 2019 Sep; 9(9):CD006924. PubMed ID: 31553802 [TBL] [Abstract][Full Text] [Related]
35. Intermittent inhaled corticosteroid therapy versus placebo for persistent asthma in children and adults. Chong J; Haran C; Chauhan BF; Asher I Cochrane Database Syst Rev; 2015 Jul; 2015(7):CD011032. PubMed ID: 26197430 [TBL] [Abstract][Full Text] [Related]
36. Long-acting inhaled therapy (beta-agonists, anticholinergics and steroids) for COPD: a network meta-analysis. Kew KM; Dias S; Cates CJ Cochrane Database Syst Rev; 2014 Mar; 2014(3):CD010844. PubMed ID: 24671923 [TBL] [Abstract][Full Text] [Related]
37. Long-acting beta2-agonist in addition to tiotropium versus either tiotropium or long-acting beta2-agonist alone for chronic obstructive pulmonary disease. Farne HA; Cates CJ Cochrane Database Syst Rev; 2015 Oct; (10):CD008989. PubMed ID: 26490945 [TBL] [Abstract][Full Text] [Related]
38. Regular treatment with formoterol and an inhaled corticosteroid versus regular treatment with salmeterol and an inhaled corticosteroid for chronic asthma: serious adverse events. O'Shea O; Stovold E; Cates CJ Cochrane Database Syst Rev; 2021 Apr; 4(4):CD007694. PubMed ID: 33852162 [TBL] [Abstract][Full Text] [Related]
39. Effects on resource utilization of adding salmeterol in combination or separately to inhaled corticosteroids. Chan J; Hui RL; Spence MM J Manag Care Pharm; 2007; 13(1):21-7. PubMed ID: 17269833 [TBL] [Abstract][Full Text] [Related]
40. Safety of regular formoterol or salmeterol in children with asthma: an overview of Cochrane reviews. Cates CJ; Oleszczuk M; Stovold E; Wieland LS Cochrane Database Syst Rev; 2012 Oct; 10(10):CD010005. PubMed ID: 23076961 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]